Sensei Biotherapeutics

senseibio.com

Sensei Biotherapeutics is a clinical-stage biotechnology company focused on developing conditionally active antibodies that selectively target the tumor microenvironment to enhance the immune system's ability to fight cancer. Their innovative approach aims to unlock previously undruggable targets, providing new treatment options for cancer patients. With a strong leadership team and a pipeline of investigational therapies, Sensei is positioned to make significant contributions to the field of immuno-oncology, addressing unmet medical needs in cancer treatment.